Do you qualify for compensation? Find Out Now (30-second survey)

(800) 511-3838 |

What They Knew

“There is absolutely an increased risk of amputation with canagliflozin,” according to that trial, Mahaffey said. Even so, he said, “We have to put the risk of amputations in perspective with the clear benefits we are seeing”.

While Janssen Pharmaceuticals tested their drug to measure glucose levels, they failed to fully monitor the painful effects that could put patients in harm’s way. This is important to know because canagliflozin is a newer drug that worked in a completely different way than previous diabetes medications (it blocks glucose absorption that takes place in the kidneys and releases the excess glucose through the urine).

When They Knew It

Invokana was approved by the FDA in March 2013. By June 2015, the European Medicines Agency (which is similar to our FDA) started to evaluate the risk of canagliflozin due to the high number of complaints they were receiving. This was almost a full two years before the FDA put out a safety communication warning patients and doctors of the increased potential for amputations.

Millions of patients took Invokana and Invokamet, and hundreds of thousands have experienced painful, life-altering injuries even after many complaints were filed. Brenda Lozano of Texas took Invokana for a little over two years and suffered severe kidney damage which later resulted in a stroke. Brenda has accumulated expensive medical bills and she now has to live with the lifelong physical complications of her injuries.

Polley Dailey of Kentucky took Invokana for just over a year and then had to endure the amputation of her right leg. Brenda, Polley and many others are taking Janssen Pharmaceuticals to court because: 1. the new medication was never fully tested resulting in patients being the guinea pigs and 2. patients and doctors weren’t warned of the true extent of the risks involved with these medications. Janssen Pharmaceuticals misrepresented their drug as a safe option when they fully knew the potential harm that patients might experience.

In fact, in December 2017, over 990 Invokana cases had been consolidated in multidistrict litigation (MDL) in New Jersey. While this number may seem low, who knows how many Polleys or Brendas are out there?

Can I Make a Claim?

Did you take Invokana or Invokamet and suffered from an amputation? You may be able to make a claim if you meet the following qualifications:

  • You started taking Invokana after March 2013 OR
  • You started taking Invokamet after August 2014
  • You or a loved one experienced an amputation (or multiple amputations) involving toes, a foot or a leg.

Maybe you (or someone you know) have endured this horrible situation and now you have overwhelming medical bills, costly medications and you’ve lost time at work. Janssen Pharmaceuticals should have tested their medications thoroughly before putting it on the market to ensure that it was safe for patients and they should have told doctors and patients of the increased risk for amputations. Contact us today to see if we’re able to help you get the compensation that you deserve.

Invokana/Invokamet Warnings In The News

BREAKING (6/18/2018): FDA Requests Invokana Label Review Extension Due to Increased Risk of Amputations

In order to change a drug label, market a new dosage or strength of a drug, or change the way a drug is made, a pharmaceutical company must first submit a supplemental new drug application (sNDA) to the FDA. Johnson & Johnson, the makers of the type 2 diabetes drug Invokana (canagliflozin), recently submitted an sNDA application so that it’s label could add that Invokana reduces the risks of cardiovascular events in type II diabetes patients who are potentially at risk for cardiovascular (CV) disease. Invokana – along with its fixed-dose combinations Invokamet and Invokamet XR – is a sodium-glucose co-transporter-2 (SGLT2) inhibitor that is used for treating type 2 diabetes.

Unfortunately, Invokana currently has a black box warning – the highest warning given by the FDA – for the increased risk of amputations. Do the benefits of reduced cardiovascular complications outweigh the high risk for amputations?

Read Full Article

3/1/2018: Lawsuit Blames Invokana For Toe Amputation

According to a February 14th filing in the U.S. District Court, District of New Jersey, Richard Greenhut was prescribed Invokana in 2016 and took it as directed. On January 12, 2017, he was hospitalized for a swollen, ulcerated and malodorous second right toe, osteomyelitis and renal failure, which he claims were the direct result of his Invokana use. At that time, Greenhut underwent surgical amputation of the affected toe.

The plaintiff was readmitted to the hospital on January 25th due to ongoing ulceration and osteomyelitis. That same day, Greenhut underwent a right second ray partial amputation, which involved the removal of the corresponding metacarpal bones in the foot. He is now permanently disfigured and injured.

Read Full Article

8/31/17: Doctors Debate Danger of Popular Diabetes Drug After FDA Amputation Warning

Many San Diego doctors are taking their patients off of Invokana, a widely used diabetes drug, after a large industry-sponsored trial found it doubled the risk of lower limb amputations compared with those taking a placebo.

Patients are being switched to other medications even though the study’s authors say the drug’s benefits — a reduced risk of cardiovascular events including death, non-fatal heart attacks and non-fatal strokes — outweigh its risk of amputations.

The drug is prescribed for people with Type 2 diabetes. The patients in the trial were already at high risk for heart disease and other diabetes complications including amputations.

Read Full Article

6/12/17: Johnson & Johnson Drug Prevents Heart Attacks At Cost Of Amputated Toes

Invokana, a diabetes drug made by Johnson & Johnson, decreases the risk of heart attacks and strokes, but also increases the risk of amputation, particularly of toes.

The study also deepens the mystery about such drugs, known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which prevent the kidney from absorbing sugar from the blood. This lowers blood sugar, is good for the kidney, but leads to more urinary tract infections and weakened bones. But scientists are not sure why the drugs would prevent cardiovascular disease, and it’s entirely unclear why one of them would lead to amputations. “It justifies the need to test each medicine,” says Harlan Krumholz, of Yale University.

Read Full Article

5/18/16: Interim clinical trial results find increased risk of amputations with [Invokana]; FDA to investigate

The U.S. Food and Drug Administration (FDA) is alerting the public about interim safety results from an ongoing clinical trial that found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with the diabetes medicine canagliflozin (Invokana, Invokamet). We have not determined whether canagliflozin increases the risk of leg and foot amputations. We are currently investigating this new safety issue and will update the public when we have more information.

Patients should not stop or change their diabetes medicines without first talking to their health care professional. Doing so can lead to uncontrolled blood sugar levels that can be harmful. Over time, this can cause serious problems, including blindness, nerve and kidney damage, and heart disease. Patients taking canaglifozin should notify their health care professionals right away if they notice any new pain or tenderness, sores or ulcers, or infections in their legs or feet.

Read Full Article


5/15/15: FDA warns that [Invokana] may result in a serious condition of too much acid in the blood


The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization.

Patients should pay close attention for any signs of ketoacidosis and seek medical attention immediately if they experience symptoms such as difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness. Do not stop or change your diabetes medicines without first talking to your prescriber. Health care professionals should evaluate for the presence of acidosis, including ketoacidosis, in patients experiencing these signs or symptoms; discontinue SGLT2 inhibitors if acidosis is confirmed; and take appropriate measures to correct the acidosis and monitor sugar levels.

Read Full Article


Filed Invokana Complaints & Damages

7/6/17: Dailey V. Janssen Pharmaceuticals, Inc.
5/26/17: Lozano V. Janssen Pharmaceuticals, Inc Et Al

As a result of the defective nature of INVOKANA, persons who were prescribed and ingested INVOKANA, including Plaintiff, have suffered and may continue to suffer severe and permanent personal injuries, including a stroke. 4. After beginning treatment with INVOKANA, and as a direct and proximate result of Defendants’ actions and inaction, Plaintiff developed kidney failure. Plaintiff’s ingestion of the defective and unreasonably dangerous drug INVOKANA has caused and will continue to cause injury and damage to Plaintiff

Read Full Case

Invokana Settlement Information


Invokana/Invokamet settlements are now being negotiated, but there is a limited window to pursue help. If you think you, a friend, or a family member may qualify, get your free case review today… before it’s too late!

  • * Submit now to learn if you may be eligible for a cash settlement or call (800) 511-3838 now.

Our in-house legal counsel, Matthew J. Daher, earned his Bachelor of Arts degree from the University of Utah and his law degree from the University of Missouri – Columbia School of Law. Matt has devoted his entire practice to civil litigation, and has spent his career representing the rights of individuals who have been injured by pharmaceuticals, medical devices, medical malpractice, defective products, and motor vehicle accidents. As in-house counsel for Periscope Group, Matt leads our internal legal team and liaises with our external partners.

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device


70% Of News Advertising Now Belongs to Big Pharma

If you watch television for any amount of time, you’re probably going to see a drug commercial that tugs on your heart strings, promises to heal your worst medical conditions, and then a voiceover will quickly gloss over the multitude of side effects in a too-quick-to-understand string of monotone words. Prescription medications are are multi-BILLION dollar industry that’s making not only the pharmaceutical companies tons of money, but also the network television stations. How is this influencing public opinion AND health?

70% Of News Advertising Belongs to Big Pharma

As we casually watch TV, we usually don’t think twice about these drug ads, but let’s take a glimpse behind the screen. Did you know that pharmaceutical advertising has soared 62 percent since 2012 and is projected to cost $610 billion by 2021? Worse yet, nine out of the 10 largest revenue-generating pharmaceutical companies spend more on advertising than they do on research and development (it appears that they care more about selling drugs than making sure that they are safe and effective). Equally concerning is that pharmaceutical advertising is banned in just about every country except the United States and New Zealand. And consider this: the average American watches 16 hours of pharmaceutical commercials each year which is more time than they spend with their primary physician. One-third of these people ask their doctors about a drug advertisement and most request a prescription.

Clearly this type of advertising in generating a huge response from the public, but it also is having an impact that consumers rarely think about: if these companies are paying television networks billions of dollars to advertise their drugs, would their news stations risk losing big money accounts by reporting negative information about the company? Public figure and activist Robert F. Kennedy Jr. once shared that, “I ate breakfast last week with the president of a network news division and he told me that during non-election years, 70% of the advertising revenues for his news division come from pharmaceutical ads. And if you go on TV any night and watch the network news, you’ll see they become just a vehicle for selling pharmaceuticals. He also told me that he would fire a host who brought onto his station a guest who lost him a pharmaceutical account.”

I had a history professor say that products were made much better in the 1940’s and 50’s. For example, you could buy a toaster once and you’d never have to buy another one because it was made so well. The problem was that these quality products actually hurt revenue since it was a one time purchase. Nowadays, you buy a toaster, it breaks a few years later, and then you go back and buy another one. This same philosophy can be said for big pharma.

“Thanks to government protections [big pharma is] able to make their products more addicting and less effective so they can create return customers and extend their profits,” explains investigative journalist John Vibes. “If a medication is effective in curing a patient then they won’t continually use and purchase that drug because they will have no need to do so. However, if the drug is mediocre and has addictive properties then it will become a regular part of the patient’s monthly budget.”

Mass advertising is clearly one way to start this cycle of addiction. Furthering this point, just this month opioid manufacturer Purdue Pharma announced that they are giving a $3.4 million grant to a non-profit company to help develop low-cost naloxone nasal spray, an antidote for those who overdose on opioids. So let’s get this straight: instead of creating preventative measures to reduce opioid usage and address the true underlying problems, they’re creating a drug to try and solve a major drug epidemic. Anyone else see the flaw in this thinking?

Every drug has its benefits and risks, and it’s time that we, as consumers, educate ourselves to make the best choices for our health. We need to read up on prospective medications, really talk to our doctors, and maybe, just maybe, turn the channel when that drug commercial comes on.


“Robert F Kennedy Jr. Says 70% Of News Advertising Revenue Comes From Big Pharma.” True Activist. Accessed September 7, 2018.
“Is Direct-to-Consumer Pharmaceutical Advertising Right for You?” Harvard Political Review. Accessed September 7, 2018.

Vaginal Stones vs. Vaginal Mesh: Are We Scared of the Wrong Product?

Recently celebrity and health guru Gwyneth Paltrow and her company, Goop, Inc., was hit with a $145,000 settlement due to a California complaint that her vaginal “eggs” and certain essential oils were falsely advertised on her website. What we want to know is, why was Paltrow held accountable for her misleading claims, but the medical device companies are still allowed to promote transvaginal mesh (TVM) which is much more dangerous and life-altering? These eggs may not live up to the hype, but they also don’t slice organs and tissue, cause chronic pain, and prevent a sex life like TVM does. It’s like prosecuting a jay walker and letting a murderer walk away free.

California is scolding Gwyneth Paltrow for overselling vaginal eggs but fails to hold Big Pharma accountable for TVM that irreparably destroys women’s vaginas. Shame on you, CA!

According to Patch,com, “The Napa-filed complaint was directed at ‘unsubstantiated representations regarding the effects or attributes’ of three products—the Jade Egg and Rose Quartz Egg, egg-shaped stones designed to be inserted vaginally and left in for various lengths of time, and Inner Judge Flower Essence Blend, essential oils meant be taken orally or added to bathwater — that were not supported by competent and reliable scientific evidence, said district attorneys from Napa and Santa Clara counties.”

The goop (yep, spelled with a lowercase “g”), website states that the Rose Quartz eggs are, “Made of heart-activating rose quartz—associated with positive energy and love—this yoni egg is associated with the heart chakra“ and that the Jade Egg is, “Used by women to increase sexual energy—this yoni egg is made of nephrite jade stone, meant to promote health and pleasure.” (The Inner Judge Flower Essence Blend is no longer available on the website.)

Do you qualify for compensation?

Do you qualify for compensation?

Transvaginal Mesh victims have a limited window to pursue help. Take our 30-second survey to see if you or a loved one may qualify... before it's too late.

So are these products a little weird? Yeah. Will they really improve “sexual energy”? Maybe not. Are they dangerous? No complaints have been filed. Is there scientific evidence backing up these claims? Nope.

But let’s look at TVM. Is this weird? Yeah, it’s a plastic strip of window screen that holds up your organs. Does it live up to the claims of addressing stress urinary incontinence (SUI) and pelvic organ prolapse (POP)? Sometimes, but at what risk? Are they dangerous. Absolutely! Millions of women have reported complications including multiple surgeries, inability to work, not able to have children, constant pain, broken relationships, and other conditions that have left them depressed, in agony, and struggling to find the strength and hope to face each day. Were there scientific studies proving the effectiveness of this product? No. Mesh had never been tested in a vagina before it was put into millions of women. Actually, studies have proven that it puts women’s health at risk!

The questions now remains: why did California spend time and resources one an unusual product that showed no harm while TVM which causes permanent damage is legal? We don’t need the government to focus on a celebrity and her website, we need them to keep big pharma accountable for the products that are disabling and even killing innocent people.

We can’t let Big Pharma get away with this!

Share now to stand up, spread the word, and protect the women you love. Just click the image below.

Sexism at the Doctor’s Office

Dr. Gary Tigges, an internal medicine specialist in Plano, Texas is getting a lot of press these days for a comment he said in a Dallas medical journal. Dr. Tigges stated:

“Female physicians do not work as hard and do not see as many patients as male physicians. This is because they choose to, or they simply don’t don’t want to be rushed, or they don’t want to work the long hours. Most of the time, their priority is something else … family, social, whatever.”

Nothing needs to be ‘done’ about this unless female physicians actually want to work harder and put in the hours. If not, they should be paid less. That is fair.”


Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

HON Code Certification

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

Protected by Copyscape

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

HON Code Certification

Pin It on Pinterest